Last reviewed · How we verify
Control vaccine younger adults
Control vaccine younger adults is a Biologic drug developed by Arcturus Therapeutics, Inc.. It is currently in Phase 1 development. Also known as: Influenza vaccine.
At a glance
| Generic name | Control vaccine younger adults |
|---|---|
| Also known as | Influenza vaccine |
| Sponsor | Arcturus Therapeutics, Inc. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- A Study on the Safety, Reactogenicity and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults (PHASE1)
- A Study to Find the Dose and Assess the Immune Response and Safety of a Vaccine Against Influenza in Healthy Younger and Older Adults (PHASE2)
- Safety and Immunogenicity Study of Self-Amplifying RNA Pandemic Influenza Vaccine in Adults (PHASE1)
- Safety and Immunogenicity First-in-human Dose-ranging Study of Self-Amplifying RNA Seasonal Influenza Vaccine in Adults (PHASE1)
- A Study of RSV-HMPV Bivalent Vaccine VXB-241 in Older Adults (PHASE1)
- A Study of an Investigational Flu Seasonal/SARS-CoV-2 Combination Vaccine in Adults (PHASE1)
- A Study to Assess the Safety and Immune Response of a Vaccine Against Influenza in Healthy Younger and Older Adults (PHASE1, PHASE2)
- A Trial Evaluating the Safety and Effects of an RNA Vaccine ARCT-021 in Healthy Adults (PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Control vaccine younger adults CI brief — competitive landscape report
- Control vaccine younger adults updates RSS · CI watch RSS
- Arcturus Therapeutics, Inc. portfolio CI
Frequently asked questions about Control vaccine younger adults
What is Control vaccine younger adults?
Control vaccine younger adults is a Biologic drug developed by Arcturus Therapeutics, Inc..
Who makes Control vaccine younger adults?
Control vaccine younger adults is developed by Arcturus Therapeutics, Inc. (see full Arcturus Therapeutics, Inc. pipeline at /company/arcturus-therapeutics-inc).
Is Control vaccine younger adults also known as anything else?
Control vaccine younger adults is also known as Influenza vaccine.
What development phase is Control vaccine younger adults in?
Control vaccine younger adults is in Phase 1.
Related
- Manufacturer: Arcturus Therapeutics, Inc. — full pipeline
- Also known as: Influenza vaccine
- Compare: Control vaccine younger adults vs similar drugs
- Pricing: Control vaccine younger adults cost, discount & access